EKIMAS Corporation (ASNB) Research

Currently, EKIMAS Corporation does not engage in significant business operations. In its earlier years, the company focused on creating specialized polymer materials used in the development of medical devices, designed to address various anatomical regions and health issues. The firm's current objective is to identify, acquire, or combine with an existing operating entity through an equity-for-equity transaction. Established in 1993, this Las Vegas, Nevada-based entity was formerly known as AdvanSource Biomaterials Corporation, changing its name to EKIMAS Corporation in March 2020.

Market snapshot

Symbol
ASNB
Price
$0.85
Day change
+6.58%
Market cap
$47.2M
P/E ratio
-10.22x
52-week range
0.55-1.7
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • China Dasheng Biotechnology Company (CDBT)
  • Eat & Beyond Global Holdings Inc. (EATBF)
  • Engage Mobility, Inc. (ENGA)
  • EZRaider Co. (EZRG)
  • Fuel Doctor Holdings, Inc. (FDOC)
  • Global Developments, Inc. (GDVM)
  • The Healing Company Inc. (HLCO)
  • Metro Inc. (MTRI)

Open EKIMAS Corporation (ASNB) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.